SBFM FY 2016 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$60,731

Operating Income

-$993,108

Net Income

-$3M

EPS (Diluted)

$-164.63

Cash Flow

Operating Cash Flow

-$314,182

Free Cash Flow

-$317,621

Stock-Based Comp.

$702,300

Balance Sheet

Total Assets

$64,404

Total Liabilities

$274,104

Stockholders' Equity

-$209,700

Cash & Equivalents

$57,453

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1,708	-100.0%
Gross Profit	-$60,731	-$383,000	+84.1%
Operating Income	-$993,108	-$780,000	-27.3%
Net Income	-$3M	-$2M	-111.5%